Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol

H. B. Rubins, S. J. Robins, D. Collins

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish (US)
Pages (from-to)49
Number of pages1
JournalEvidence-Based Medicine
Volume5
Issue number2
DOIs
StatePublished - Mar 2000

Cite this